· Current Price – $0.0419 · Best Case Scenario PT over 1$ · Market Cap – $11 million · Debt – 0 Halbert Corporation Are a biomedical company with a clear aim to revolutionize the world of medicine. They are working towards a creation of variety of antibodies and treatments using extracorporeal techniques (outside of body). They believe they have the...
Just interesting that Moderna (MRNA) was taking off while Pfizer (PFE) was declining.
I want to apologize for my lack of activity the past few months. A lot has changed in the markets and a lot has evolved in my approach to reading and navigating the markets. When it comes to my process, I have added the use of multiple lenses beginning first with a fundamental macro overlay called the GIP (Growth, Inflation, Policy) Quad Model, which give us 4...
POSSIBLE PATTERN : - BULLISH PENNANT -------------------------------- ※ DON'T FORGET TO USE TRAILING STOP 5% ※ ENTRY BUY: - BUY ON BREAK OUT: 1645 - ENTRY BUY AT RANGE PRICE OF 1615 - 1665 (OPTIONAL) (CLOSEST RESISTANCE TO BE BREAK IS AT 1685) --------------------------------------------------------------------------- ※ TARGET PROFIT 1: 1875 (FIBONACCI...
MYX:HWGB-WD is poised to retest its .815 retracement level after successfully broken the downtrend resistance. It has also succesfully bounced from the RBS and now is ready to fly to the next roof. Currently its mother trades just shy below RM1 while its peers like MYX:SOLUTN and MYX:BINTAI had already broken past RM1 and maintain above that level. We...
An interesting trend on BNTX, complete wave II with a clear end of correction on main channel. Wave III is currently underway. Hope you find the chart interesting. Please leave a like or drop your comment below and follow me for more updates. DISCLAIMER: This MUST NOT be taken as a trading signal.
No one can predict the result of NVAX's phase 3 trial. However, I don't count out any potential winners in the vaccine race even though now it seems very likely that NVAX won't be the first one to distribute vaccines at massive scale. That being said, as long as the result of phase 3 trial isn't a complete failure, I think the crowd frenzy will keep pushing...
S&P 500 Index (SPX) (October 26th through November 9th 2020) Low: 3362.9 points High: 3455 points How E-mini futures market started off yesterday: My previous SPX forecast: My adjustments today are more to correct the trajectory and duration I was originally expecting. Will be interesting to see how this spooky week turns out. Time for temporary...
90 million vaccines have just been purchased by the UK government and the US is also in talks to purchase COVID-19 vaccines.
If the Johnson & Johnson COVID-19 vaccine does well in final phase testing, this could cause the share price to break out from the current bull flag formation, if not we will see a break to the downside.
The price could go either way depending on the results from clinical trials of their Covid-19 vaccine.. so watch this space for confirmation either way.
I am looking for a breath through of resistance, followed by confirmation that the resistance becomes support as a signal to buy the next bull run for Moderna on the daily time frame.
Preliminary studies on coronavirus vaccines have produced promising results. I'm still a believer in their technology. Check out my previous NVAX posts and/or the first one. They have a promising technology that could revolutionize the vaccine industry. We (humanity) are already very behind in how we produce vaccines AKA using chicken eggs. So Novavax will...
On its earnings report today, Microsoft reported better-than-expected earnings and guidance, but issued first-quarter revenue guidance slightly below the Wall Street consensus. The poor revenue guidance was partly, but not completely, offset by slightly better-than expected guidance for first-quarter operating costs. Overall, the magnitude of the earnings beat was...
Whats going on yall... So, taken a look at VBIV, Im pretty sure you heard of Covid-19??? OK, well, here's 1 of the hypes that could kick in probably #TradeSafe #InvestSmart NASDAQ:VBIV